“…Although the implementation of these NPIs was developed to contain COVID-19, many studies had showed it also help decrease the activity of other airborne/droplet-transmitted infectious diseases, such as influenza, invasive pneumococcal diseases (IPD), and measles [6] , [7] , [8] , [9] , [10] , [11] . In contrast, the effect of NPIs on the epidemiology of non-airborne/droplet-transmitted infectious diseases was rarely reported and most of them were conducted during the first wave of COVID-19 [12] , [13] , [14] , [15] , [16] , [17] . To better understand the long-term effect of COVID-19 on the activity of non-airborne/droplet-transmitted infectious diseases, this study was conducted to compare the case number of non-airborne/droplet-transmitted notifiable infectious disease (NID) between pandemic period and the pre-pandemic period.…”